Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M P King

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
ALTEX|October 23, 2024
Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testingThomas Hartung, Nicholas M P King, Nicole Kleinstreuer, et al.
Cardiovascular Toxicology|February 27, 2010
Exposure to low-dose trichloroethylene alters shear stress gene expression and function in the developing chick heartOm Makwana, Nicholas M P King, Lauren Ahles, et al.
The Journal of General Physiology|December 29, 2010
Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cellsNicholas M P King, Methajit Methawasin, Joshua Nedrud, et al.
Clinical and Translational Science|June 10, 2026
Characterization of Urinary Kidney Injury Biomarker Profiles in Healthy Japanese Subjects With Reference to a Counterpart US StudyTakehiko Sambe, Takuya Mizukami, Nicholas M P King, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2024
Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humansJiri Aubrecht, David Potter, John Michael Sauer, et al.
Clinical Pharmacology and Therapeutics|November 24, 2025
Biomarkers of Drug-Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug DevelopmentTanja S Zabka, Michael Lawton, Tom Chu, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Circulation|July 9, 2004
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathySherif F Nagueh, Gopi Shah, Yiming Wu, et al.
Database : the Journal of Biological Databases and Curation|February 2, 2026
predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugsJens Hansen, Pedro Martinez, Arjun S Yadaw, et al.
Journal of Pharmacological and Toxicological Methods|October 31, 2015
Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in ratPetra Vinken, William J Reagan, Luis A Rodriguez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
ALTEX|October 23, 2024
Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testingThomas Hartung, Nicholas M P King, Nicole Kleinstreuer, et al.
Cardiovascular Toxicology|February 27, 2010
Exposure to low-dose trichloroethylene alters shear stress gene expression and function in the developing chick heartOm Makwana, Nicholas M P King, Lauren Ahles, et al.
The Journal of General Physiology|December 29, 2010
Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cellsNicholas M P King, Methajit Methawasin, Joshua Nedrud, et al.
Clinical and Translational Science|June 10, 2026
Characterization of Urinary Kidney Injury Biomarker Profiles in Healthy Japanese Subjects With Reference to a Counterpart US StudyTakehiko Sambe, Takuya Mizukami, Nicholas M P King, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2024
Serum glutamate dehydrogenase activity enables sensitive and specific diagnosis of hepatocellular injury in humansJiri Aubrecht, David Potter, John Michael Sauer, et al.
Clinical Pharmacology and Therapeutics|November 24, 2025
Biomarkers of Drug-Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug DevelopmentTanja S Zabka, Michael Lawton, Tom Chu, et al.
Bioanalysis|August 12, 2025
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for BiomarkersKaren J Quadrini, Jiri Aubrecht, Nicholas M P King, et al.
Circulation|July 9, 2004
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathySherif F Nagueh, Gopi Shah, Yiming Wu, et al.
Database : the Journal of Biological Databases and Curation|February 2, 2026
predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugsJens Hansen, Pedro Martinez, Arjun S Yadaw, et al.
Journal of Pharmacological and Toxicological Methods|October 31, 2015
Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in ratPetra Vinken, William J Reagan, Luis A Rodriguez, et al.
Pageof 2